Title : Molecular mechanisms of ezetimibe-induced attenuation of postprandial hypertriglyceridemia.

Pub. Date : 2010 Sep 30

PMID : 20543519






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Both TG content and ApoB-48 mass were decreased in ezetimibe-treated mice. Ezetimibe apolipoprotein B Mus musculus
2 The quantitative RT-PCR of intestinal mucosa showed down-regulation of the mRNA expression of FATP4 and ApoB in both groups along with FABP2, DGAT1, DGAT2 and SCD1 in WT mice at postprandial state after ezetimibe treatment. Ezetimibe apolipoprotein B Mus musculus
3 CONCLUSION: Ezetimibe alone reduces PHTG by blocking both the absorption of cholesterol and the intracellular trafficking and metabolism of long-chain fatty acids in enterocytes, resulting in the reduction of the formation of ApoB-48 which is necessary for the ApoB48-containing lipoprotein production in the small intestines. Ezetimibe apolipoprotein B Mus musculus
4 CONCLUSION: Ezetimibe alone reduces PHTG by blocking both the absorption of cholesterol and the intracellular trafficking and metabolism of long-chain fatty acids in enterocytes, resulting in the reduction of the formation of ApoB-48 which is necessary for the ApoB48-containing lipoprotein production in the small intestines. Ezetimibe apolipoprotein B Mus musculus